A Study of Inclisiran to Prevent Cardiovascular Events in High-risk Primary Prevention Patients.
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
Clinical Trials Related to Novartis Pharmaceuticals
Related studies linked through entity extraction aliases.
Nilotinib for Patients With Chronic Myeloid Leukemia in First Line and Any Subsequent Line
- Status
- COMPLETED
- Phase
- N/A
The Belgian REAL (BE.REAL) Registry
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- N/A
A Prevention Trial of Canakinumab in Subjects at High Risk for Lung Cancer
- Status
- TERMINATED
- Phase
- PHASE3
DETERMINE (Determining Extended Therapeutic Indications for Existing Drugs in Rare Molecularly Defined Indications Using a National Evaluation Platform Trial) - Master Screening Protocol
- Status
- RECRUITING
- Phase
- PHASE2/PHASE3
Study of Efficacy and Safety of Secukinumab in Participants With Moderate-severe Rotator Cuff Tendinopathy
- Status
- TERMINATED
- Phase
- PHASE3
Retrospective Assessment of Adverse Events-related Healthcare Resource Utilization and Costs of Immune Checkpoint Inhibitor and Targeted Therapy for Adjuvant Treatment of Melanoma
- Status
- COMPLETED
- Phase
- N/A
Study to evaLuate the effIcacy and Safety of abeLacimab in High-risk Patients With Atrial Fibrillation Who Have Been Deemed Unsuitable for Oral antiCoagulation (LILAC-TIMI 76)
- Status
- RECRUITING
- Phase
- PHASE3
A Post Approval Commitment Study on Tabrecta® (Capmatinib) in South Korea
- Status
- RECRUITING
- Phase
- N/A
Ribociclib Real-world Treatment Patterns and Clinical Outcomes Among Women With HR+/HER2- Advanced or Metastatic Breast Cancer in France
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- N/A
Long-term Safety and Tolerability of Inclisiran in Participants With HeFH or HoFH Who Have Completed the Pediatric ORION-16, ORION-13, ORION-20, or ORION-19 Studies
- Status
- RECRUITING
- Phase
- PHASE3
Long-term Extension Study of Ligelizumab in Food Allergy
- Status
- TERMINATED
- Phase
- PHASE3
Secukinumab (Cosentyx®) Effectiveness in Axial Spondyloarthritis and Psoriatic Arthritis Patients Using Artificial Intelligence (SpAINET): Spanish Multicenter, Retrospective, Real World Evidence Study
- Status
- COMPLETED
- Phase
- N/A
24 Weeks Double-blind Randomized Placebo-controlled Trial to Evaluate Efficacy, PK, Safety of LOU064 in Adolescents (12 - <18) With CSU and Inadequate Response to H1-antihistamine Followed by Optional 3 Years Open-label Extension and an Optional 3 Years Safety Long-term Treatment-free Follow-up
- Status
- RECRUITING
- Phase
- PHASE3
Real-World Assessment of Clinical Outcomes in Metastatic NSCLC Patients With MET Exon 14 Skipping Mutation and Brain Metastases Treated With Capmatinib
- Status
- COMPLETED
- Phase
- N/A
A Study to Evaluate the Efficacy, Safety, Pharmacokinetics and Dosimetry of [177Lu]Lu-PSMA-617 in Chinese Adult Male Patients With Progressive PSMA-Positive mCRPC
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Study Assessing the Efficacy and Safety of a Personalized Monotherapy Regimen of Brolucizumab in Patients With Symptomatic Macular Polypoidal Choroidal Vasculopathy
- Status
- COMPLETED
- Phase
- PHASE3
An Open-label, Adaptive Design, Positron Emission Tomography Study in Healthy Male Participants to Characterize Receptor Occupancy by MIJ821 in the Brain
- Status
- COMPLETED
- Phase
- PHASE1
Alpelisib/iNOS Inhibitor/Nab-paclitaxel in Patients With HER2 Negative Metaplastic Breast Cancer (MpBC)
- Status
- RECRUITING
- Phase
- PHASE2
A Study Evaluating [177Lu]Lu-PSMA-617 vs. a Change of Androgen Receptor-directed Therapy in Taxane Treatment Naive Chinese Male Patients With Progressive Metastatic Castrate Resistant Prostate Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2